USPTO provides additional guidance for taking advantage of the patent related deadline extension available under CARE Act. To seek the extension, the patent applicants will need to submit a statement explaining that the delay in filing or making a payment was due to the COVID-19 outbreak. Such statements should not be made blindly. They constitute a certification under 37 CFR § 11.18(b). Violations of 37 CFR § 11.18(b) may be subject to sanctions pursuant to 37 CFR § 11.18(c).
